Biologics Supplier for Orthopedic Practices in Jacksonville, FL

How orthopedic practices typically qualify a biologics vendor

Orthopedic groups and ambulatory surgery centers generally route a new tissue or biologics vendor through a purchasing or compliance review before any product reaches an exam room. That review typically asks for the supplier's donor eligibility and screening summary, a description of recovery and processing timelines, and a certificate of analysis for the specific lot under consideration. Larger multi-surgeon practices in markets like Jacksonville often also confirm that ordering will route through a single designated purchaser so that lot numbers and receiving records stay consistent across locations.

• Donor eligibility and screening summary
• Certificate of analysis by lot
• Description of recovery and processing timelines
• Storage and handling instructions for the specific format ordered

Setting up an NPI-verified account

Precision Biologics opens accounts for licensed providers and clinics, and account verification requires an NPI number on file. This matches how most orthopedic practices already structure vendor relationships, since an NPI ties ordering activity to a specific practice location rather than an individual staff member. Once an account is verified, the practice's designated contact can request documentation for any product or lot before placing an order.

Cold-chain shipping and receiving for Southeast practices

Cryopreserved products ship overnight on dry ice in validated containers, and a Jacksonville practice receiving a shipment should have a staff member available to confirm the container temperature and tissue lot number against the packing slip at intake. Because tracking is maintained at the lot level, the receiving record a practice keeps should reference the same lot identifier that appears on the certificate of analysis. Freeze-dried formats do not require the same cold-chain handling but still arrive with lot-specific documentation.

Confirming regulatory standing before ordering

Any orthopedic practice evaluating a new supplier should confirm its own standing with the Florida Board of Medicine and consult its own legal counsel on how a given product and intended use fit within applicable rules, rather than relying on a supplier's description of its own compliance. Florida's SB 1768, effective 2025-07-01, allows physicians to use certain non-FDA-approved stem cell therapies in orthopedics, wound care and pain management under informed consent and disclosure requirements, but it is a state framework and does not change federal FDA rules that apply to the product itself. Precision Biologics does not advise on clinical use, dosing or procedures; a Precision Biologics account manager can schedule a peer-to-peer call between a practice's medical director and ours to walk through documentation, though these calls address paperwork, not treatment decisions.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.